Is GLP-1 HRA, FSA, or HSA Eligible? Cash-Pay Guide

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you are trying to figure out whether you can use HRA, FSA, or HSA dollars for a GLP-1 medication like Wegovy, Zepbound, Ozempic, or Mounjaro, the short answer is the same one your benefits administrator will give you: it depends on your plan. The IRS treats prescribed drugs for a diagnosed disease as qualified medical expenses under Section 213(d), so GLP-1s can be eligible on paper — but employer-funded HRAs, and to a lesser extent FSAs and HSAs, are governed by plan documents that can be narrower than IRS rules. This guide walks through when GLP-1s typically clear, what documentation administrators ask for, and where the PlexusDx Weight Management Protocols — Semaglutide Injection ($149/mo), Tirzepatide Injection ($249/mo), and the Microdose GLP-1 Protocol ($129/mo flat) — sit as a cash-pay alternative when your account will not cover GLP-1s for weight loss.

Are GLP-1 medications HRA, FSA, or HSA eligible?

Often yes — with conditions. The IRS classifies prescribed drugs that diagnose, treat, mitigate, or prevent a disease as qualified medical expenses, which is the foundation that lets GLP-1 medications qualify for HRA, FSA, and HSA reimbursement at all. But eligibility under IRS rules is the floor, not the ceiling. HRAs are funded entirely by your employer and governed by an employer-written plan document that can exclude weight-loss medications, require prior approval, or demand a Letter of Medical Necessity (LMN) before reimbursement. FSAs and HSAs are governed by IRS rules more directly, but plan administrators can still require itemized receipts, prescriptions, and substantiation paperwork before paying out. The phrase “HSA/FSA eligible” on a provider page is a useful signal, not a guarantee — rules vary by plan, and you should confirm with your benefits administrator in writing before paying.

Three terms get used as if they are interchangeable, and it is worth separating them: eligible means the expense fits IRS medical-expense rules; reimbursable means your specific plan allows the expense; card accepted means the merchant’s payment processor allowed the swipe at checkout. A successful card swipe at a pharmacy or telehealth checkout does not prove your plan will accept the charge — some employer plans have warned members that GLP-1 transactions may process at the register but still get clawed back later if the plan excludes weight-loss use. Confirm before you pay.

When GLP-1 IS eligible — diagnosed conditions and FDA-labeled use

GLP-1 medications most reliably clear HRA, FSA, and HSA reimbursement when the prescription is tied to a diagnosed condition with FDA-labeled use. Type 2 diabetes is the cleanest case: Ozempic and Mounjaro are FDA-approved for type 2 diabetes, the medical necessity is built into the label, and a prescription alone is usually sufficient documentation — an LMN is typically not required. Chronic weight management in adults who meet BMI criteria is also FDA-labeled use for Wegovy (semaglutide) and Zepbound (tirzepatide), but weight-loss prescriptions more often trigger an LMN request because some plans exclude weight-loss medications even when IRS rules would allow them. Obstructive sleep apnea in adults with obesity is a separate FDA-approved indication for Zepbound that creates a second documented medical-necessity path when supported by an OSA diagnosis on file.

If your prescription is tied to a diabetes diagnosis, expect smoother HRA, FSA, and HSA clearance. If it is tied to weight management, plan for documentation requests and check your plan’s exclusions in writing before paying.

When GLP-1 ISN’T eligible — cosmetic-coded vs medically necessary

The line that separates a reimbursable GLP-1 prescription from a denied one is usually the difference between medically necessary and cosmetic use. The IRS specifically excludes expenses that are “merely beneficial to general health” from qualified medical expenses, and many HRA plan documents echo that language by excluding weight-loss medications taken without a documented medical condition. If your BMI does not meet the FDA label threshold for a weight-loss GLP-1, or if the prescription is for general wellness rather than a diagnosed condition, expect denials — even if the medication is identical to one your coworker is getting reimbursed for.

Compounded GLP-1s sit in a separate gray zone. The IRS treats prescribed compounded medicines as Section 213(d) qualified expenses when they are medical care, but some HRA plans now explicitly exclude compounded GLP-1s, and FSA and HSA administrators may require additional substantiation. As always, the plan document is the controlling rule. Get the answer from your administrator in writing before purchase.

How to claim GLP-1 on HRA, FSA, or HSA — documentation that works

If your plan allows the expense, the documentation that gets a clean reimbursement is consistent across HRA, FSA, and HSA administrators:

Prescription from a licensed clinician with the medication name, dose, and quantity.
Itemized receipt showing the patient name, date of service, medication name, and amount paid — not a credit card slip.
Diagnosis code on the prescription or the clinician’s notes when weight-management use is involved.
Letter of Medical Necessity (LMN) from the prescribing clinician for weight-loss use, stating the diagnosis, the recommended treatment, the duration, and why the medication is medically necessary. Most administrators have a template; if not, the clinician’s letterhead with the four fields above is usually sufficient.

Keep digital copies of every receipt and LMN for at least three years from the relevant tax year — longer if you can. If your plan denies a claim, the appeal window is typically short and document-driven, so an organized paper trail is worth the effort up front. And remember: you cannot double-dip. Expenses reimbursed through HRA, FSA, HSA, or Archer MSA cannot also be deducted as medical expenses on your tax return.

Cash-pay alternatives when HRA, FSA, or HSA does not cover GLP-1s

If your plan excludes weight-loss GLP-1s, your administrator denies the claim, or you simply want to avoid the documentation cycle, cash-pay compounded protocols are the most common alternative. The PlexusDx Weight Management Protocols are all-inclusive — async provider consultation, prescription, compounded medication, and shipping in one monthly price, with no membership fee:

Microdose GLP-1 Protocol — $129/mo flat. Compounded GLP-1 in four delivery variants (capsule, troche, lozenge, sublingual). Lowest entry tier and a strong fit for needle-free starters.
Semaglutide Oral — from $249/mo. Compounded oral GLP-1 receptor agonist, 3mg to 24mg daily across six dose levels.
Semaglutide Injection — $149/mo. Compounded GLP-1 receptor agonist, 0.25mg to 2.0mg weekly across five dose levels.
Tirzepatide Injection — $249/mo. Compounded GIP/GLP-1 dual-agonist, 2.5mg to 15mg weekly across six dose levels.
Tirzepatide Oral — $279/mo. Compounded oral GIP/GLP-1 dual-agonist, 5mg to 25mg daily across seven dose levels.
GLP-Squared — $249/mo. Compounded Semaglutide + Tirzepatide dual-compound therapy, six provider-titrated dose pairs.

For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148–$2,748/year on Semaglutide Injection, and $2,748–$3,708/year on Tirzepatide Injection — well below FDA-approved branded GLP-1s at retail list price (~$1,000–$1,350/month before insurance). If your prescriber recommends a genetic baseline before titration, you can add the Precision Peptide Genetic Test for $99 as an add-on after your first month on any protocol, or $298 standalone.

PlexusDx specifics — no membership, all 50 states, all-inclusive pricing

A few details that matter when you are comparing PlexusDx to other cash-pay GLP-1 options:

No membership fee. The monthly protocol price is the price — you do not pay a separate $99 or $149 membership before you can fill a prescription.
All 50 states. PlexusDx serves patients in every U.S. state. Five states require a scheduled live consultation rather than the standard async intake; the rest run async.
All-inclusive pricing. Each protocol price covers the provider consultation, the prescription, the compounded medication, and shipping. No surprise pharmacy invoices.
Compounded, not FDA-approved finished drugs. PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide from licensed U.S. compounding pharmacies. Compounded GLP-1s are not FDA-approved finished drug products; they are pharmacy-prepared formulations of the same active ingredients found in Wegovy, Ozempic, Mounjaro, and Zepbound.
Cash-pay. PlexusDx does not bill insurance and does not claim to be HRA, FSA, or HSA eligible — whether you can submit a PlexusDx receipt for reimbursement depends entirely on your plan document and administrator.

Frequently asked questions

Can I use my HRA to pay for Wegovy?

Often yes when prescribed for an indication recognized under IRS Section 213(d) and your HRA plan permits weight-loss medications. Most administrators require a Letter of Medical Necessity for weight-loss use, and some plans exclude weight-loss meds entirely — confirm in writing before paying. PlexusDx is cash-pay only and doesn’t represent itself as HRA-eligible; reimbursability depends on your plan document.

Is Ozempic HRA, FSA, or HSA eligible?

Often yes when prescribed for type 2 diabetes — the medical necessity is built into the FDA label and a prescription alone is usually sufficient documentation. Plans still control reimbursement and may require prior approval and an itemized receipt. An LMN is typically not required for diabetic use; weight-management use is more documentation-heavy.

Is Zepbound HRA-eligible for weight loss or sleep apnea?

Often yes with documentation that matches the medical record. Zepbound is FDA-approved both for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity — the OSA indication creates a second documented medical-necessity path when an OSA diagnosis is on file. Confirm with your administrator which indication and which documentation they require.

Do I need a Letter of Medical Necessity for GLP-1 reimbursement?

Sometimes. Diabetes prescriptions usually clear with the prescription alone. Weight-loss use commonly triggers an LMN request from the HRA, FSA, or HSA administrator. The standard fields are diagnosis, recommended treatment, expected duration, and why the medication is medically necessary on the prescriber’s letterhead.

Is compounded semaglutide HRA, FSA, or HSA eligible?

Possibly — the IRS treats prescribed compounded medicines as Section 213(d) qualified expenses when they are medical care, but some HRA plans now explicitly exclude compounded GLP-1s and FSA/HSA administrators may require additional substantiation. PlexusDx Semaglutide Injection and other compounded protocols can sometimes be reimbursed through these accounts, but only your plan document controls the answer. Get it in writing.

Does “HSA/FSA eligible” on a provider page guarantee my HRA will reimburse?

No — HSA/FSA eligibility is a useful signal but not proof. HRAs are employer-funded and governed by the employer’s plan document, which can be narrower than IRS rules. A successful card swipe at checkout doesn’t prove your plan will accept the charge either — some employers have warned members that GLP-1 transactions may process and still be clawed back later. Confirm before you pay.

How long do I need to keep HRA, FSA, and HSA records?

At minimum, three years from the tax return year covering the expense, and best practice is digital copies indefinitely. Keep prescriptions, itemized receipts, diagnosis codes, and any LMNs together. If a claim is denied, the appeal window is typically short and document-driven — an organized paper trail is the cheapest insurance.

Is GLP-1 HRA, FSA, or HSA Eligible? A Cash-Pay Guide With PlexusDx Pricing